Paper
23 October 2018 Metronidazole-substituted dendrimer silicon phthalocyanine: a novel photodynamic therapy photosensitizer
Author Affiliations +
Abstract
As an excellent second-generation photosensitizer for photodynamic therapy (PDT), phthalocyanine (Pc) complex has strong absorption peak in the near-infrared region and strong tissue penetrating ability, which endowed them excellent properties for the detection of tumor tissue. In recent years, in order to further ehnaced the penetration depth of the photosensitizer to the tissue, a large number of functional groups have been synthesized . In this work, we designed and synthesized metronidazole-substituted dendrimer silicon phthalocyanine (MT-SiPc) with near-infrared region Q-band of UV absorption, excellent fluorescence properties and photochemical properties.
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Qiuhao Ye, Xiangyi Han, Di Zeng, Hongqin Yang, and Yiru Peng "Metronidazole-substituted dendrimer silicon phthalocyanine: a novel photodynamic therapy photosensitizer", Proc. SPIE 10820, Optics in Health Care and Biomedical Optics VIII, 1082029 (23 October 2018); https://doi.org/10.1117/12.2500889
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Luminescence

Absorption

Silicon

Dendrimers

Photodynamic therapy

Oxygen

Tissue optics

Back to Top